drug
ferric citrate
Marketedupdated 3mo agoby $AKBA Akebia Therapeutics, Inc.
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2all catalysts(0)
nothing on the calendar yet
Trials studying ferric citrate
- phase3Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease
- phase3Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
- phase3Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease
- phase3PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD
- phase3Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 21, 2030
~3.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Jul 21, 2030method-of-use (U-2549)US 103000393.9y
- Jul 21, 2030formulationUS 93871913.9y
- Apr 21, 2026method-of-use (U-1577)US 8093423
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 19m ago
Found something off?
comments(0)
5-min edit window · permanent after that